Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 3/20 | 0.45 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.45 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.45 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.45 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31575334 | 0.96 | DPP4 (0.46) | DPP4DPP9DPP7KCNH2DPP8 | |
| SCHEMBL31575321 | 0.96 | DPP4 (0.46) | DPP4DPP9DPP7KCNH2DPP8 | |
| SCHEMBL31575328 | 0.88 | SLC6A2 (0.44) | DPP4DPP7SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL30166180 | 0.88 | SLC6A2 (0.44) | DPP4DPP7SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31575359 | 0.84 | CHRNB2 (0.43) | DPP4DPP7SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31575348 | 0.84 | CHRNB2 (0.43) | DPP4DPP7SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31575346 | 0.76 | SMN1; SMN2 (0.40) | DPP4 | |
| SCHEMBL7870941 | 0.74 | SLC6A3 (0.46) | SLC6A3 | |
| SCHEMBL14193555 | 0.72 | CHRNB4 (0.41) | — | |
| SCHEMBL10112661 | 0.71 | SLC6A2 (0.44) | SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115380030-B | N-heteroarylalkyl-2- (heterocyclyl and heterocyclylmethyl) acetamide derivatives as SSTR4 agonists | 武田药品工业株式会社 | 2025-05-16 | — | — | CN | disclosed |